Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
September 21, 2018
<sup>225</sup>Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
Mike Sathekge, Frank Bruchertseifer, Otto Knoesen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 27, 2019
Correction to: <sup>225</sup>Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
Mike Sathekge, Frank Bruchertseifer, Otto Knoesen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 23, 2017
Intraindividual Comparison of <sup>18</sup>F-PSMA-1007 and <sup>18</sup>F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study
Frederik L Giesel, Leon Will, Ismaheel Lawal, et al.
Nuclear Medicine Communications
|
December 20, 2017
68Ga-PSMA-HBED-CC PET/CT imaging in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study
Thabo Lengana, Christophe van de Wiele, Ismaheel Lawal, et al.
Nuklearmedizin. Nuclear Medicine
|
September 2, 2020
18F-FDG PET/CT imaging of vulva cancer recurrence: A comparison of PET-derived metabolic parameters between women with and without HIV infection
Kgomotso M G Mokoala, Ismaheel O Lawal, Thabo Lengana, et al.
Clinical Nuclear Medicine
|
February 25, 2021
The Association of Tumor Burden by 18F-FDG PET/CT and Survival in Vulvar Carcinoma
Kgomotso M G Mokoala, Ismaheel O Lawal, Thabo Lengana, et al.
Nuclear Medicine Communications
|
September 11, 2018
18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma
Ismaheel O Lawal, Alfred O Ankrah, Gbenga O Popoola, et al.
Nuklearmedizin. Nuclear Medicine
|
April 14, 2022
The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients with Early Recurrence after Definitive Therapy with a PSA <10 ng/ml
Thabo Lengana, Ismaheel Lawal, Charl Janse Van Rensburg, et al.
Clinical Genitourinary Cancer
|
August 19, 2018
<sup>68</sup>Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?
Thabo Lengana, Ismaheel O Lawal, Tebatso G Boshomane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 19, 2019
Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving <sup>225</sup>Ac-PSMA-617 Radioligand Therapy
Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
European Journal of Nuclear Medicine and Molecular Imaging
|
September 21, 2018
<sup>225</sup>Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
Mike Sathekge, Frank Bruchertseifer, Otto Knoesen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 27, 2019
Correction to: <sup>225</sup>Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
Mike Sathekge, Frank Bruchertseifer, Otto Knoesen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 23, 2017
Intraindividual Comparison of <sup>18</sup>F-PSMA-1007 and <sup>18</sup>F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study
Frederik L Giesel, Leon Will, Ismaheel Lawal, et al.
Nuclear Medicine Communications
|
December 20, 2017
68Ga-PSMA-HBED-CC PET/CT imaging in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study
Thabo Lengana, Christophe van de Wiele, Ismaheel Lawal, et al.
Nuklearmedizin. Nuclear Medicine
|
September 2, 2020
18F-FDG PET/CT imaging of vulva cancer recurrence: A comparison of PET-derived metabolic parameters between women with and without HIV infection
Kgomotso M G Mokoala, Ismaheel O Lawal, Thabo Lengana, et al.
Clinical Nuclear Medicine
|
February 25, 2021
The Association of Tumor Burden by 18F-FDG PET/CT and Survival in Vulvar Carcinoma
Kgomotso M G Mokoala, Ismaheel O Lawal, Thabo Lengana, et al.
Nuclear Medicine Communications
|
September 11, 2018
18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma
Ismaheel O Lawal, Alfred O Ankrah, Gbenga O Popoola, et al.
Nuklearmedizin. Nuclear Medicine
|
April 14, 2022
The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients with Early Recurrence after Definitive Therapy with a PSA <10 ng/ml
Thabo Lengana, Ismaheel Lawal, Charl Janse Van Rensburg, et al.
Clinical Genitourinary Cancer
|
August 19, 2018
<sup>68</sup>Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?
Thabo Lengana, Ismaheel O Lawal, Tebatso G Boshomane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 19, 2019
Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving <sup>225</sup>Ac-PSMA-617 Radioligand Therapy
Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
Page
of 4